文献速递糖尿病

人工智能用于糖尿病照护:现状与未来前景

Artificial intelligence for diabetes care: current and future prospects.
PubMed 文献 · Lancet Diabetes Endocrinol · 2024-01-01

本综述探讨并总结了人工智能在糖尿病照护连续体中的现状与未来前景,涵盖从提升筛查与诊断到优化治疗及预测和管理并发症。文章指出人工智能应用旨在为糖尿病患者提供个性化照护并针对复杂表现调整治疗,同时快速进展也带来潜在偏倚、伦理考量及实施挑战,确保公平部署需包容与伦理发展。

要点

  • 人工智能在糖尿病照护中的应用正被越来越多地探索,以个性化照护并适配复杂表现的治疗。
  • 人工智能快速发展带来潜在偏倚、伦理考量和实施挑战,需确保公平部署。
  • 综述覆盖糖尿病照护连续体,从筛查诊断到治疗优化及并发症预测管理。

核心结论

  • 人工智能在糖尿病照护中的应用旨在为糖尿病患者提供个性化照护并针对复杂表现调整治疗;确保包容和伦理发展的人工智能技术可赋能卫生保健提供者和糖尿病患者管理疾病。

研究设计与样本

  • 本综述探讨并总结人工智能在糖尿病照护连续体中的现状与未来前景。

主要发现

  • 人工智能应用覆盖从提升筛查与诊断到优化治疗及预测和管理并发症的糖尿病照护连续体。
  • 人工智能快速发展引入潜在偏倚、伦理考量和实施挑战,需确保公平部署。

局限性

  • 人工智能快速发展带来潜在偏倚、伦理考量和实施挑战,需确保公平部署。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Artificial intelligence (AI) use in diabetes care is increasingly being explored to personalise care for people with diabetes and adapt treatments for complex presentations. However, the rapid advancement of AI also introduces challenges such as potential biases, ethical considerations, and implementation challenges in ensuring that its deployment is equitable. Ensuring inclusive and ethical developments of AI technology can empower both health-care providers and people with diabetes in managing the condition. In this Review, we explore and summarise the current and future prospects of AI across the diabetes care continuum, from enhancing screening and diagnosis to optimising treatment and predicting and managing complications.

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Sheng B, Pushpanathan K, Guan Z, et al. Artificial intelligence for diabetes care: current and future prospects. Lancet Diabetes Endocrinol. 2024. PMID: 39054035. doi:10.1016/S2213-8587(24)00154-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。